View Item 

Show simple item record

Cyclosporine Microemulsion and Tacrolimus are Associated with Decreased Chronic Allograft Failure and Improved Long-term Graft Survival as Compared with Sandimmune

dc.contributor.authorMeier-Kriesche, Herwig-Ulfen_US
dc.contributor.authorKaplan, Bruceen_US
dc.date.accessioned2010-06-01T18:51:04Z
dc.date.available2010-06-01T18:51:04Z
dc.date.issued2002-01en_US
dc.identifier.citationMeier-Kriesche, Herwig-Ulf; Kaplan, Bruce (2002). "Cyclosporine Microemulsion and Tacrolimus are Associated with Decreased Chronic Allograft Failure and Improved Long-term Graft Survival as Compared with Sandimmune." American Journal of Transplantation 2(1): 100-104. <http://hdl.handle.net/2027.42/72045>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72045
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12095048&dopt=citationen_US
dc.format.extent82109 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science, Ltden_US
dc.rights© Munksgaard, 2002en_US
dc.subject.otherCyclosporineen_US
dc.subject.otherGraft Survivalen_US
dc.subject.otherTacrolimusen_US
dc.subject.otherTransplantationen_US
dc.titleCyclosporine Microemulsion and Tacrolimus are Associated with Decreased Chronic Allograft Failure and Improved Long-term Graft Survival as Compared with Sandimmuneen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Health System, Department of Internal Medicine, Nephrology, 3914 Taubman Center, Ann Arbor, MI 48109-0364, USAen_US
dc.identifier.pmid12095048en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72045/1/j.1600-6143.2002.020116.x.pdf
dc.identifier.doi10.1034/j.1600-6143.2002.020116.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceKahan BD, Dunn J, Fitts C et al. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995; 59: 505 – 511..en_US
dc.identifier.citedreferenceKovarik JM, Mueller EA, van Bree JB et al. Cyclosporine pharmacokinetics and variability from a microemulsion formulation – a multicenter investigation in kidney transplant patients. Transplantation 1994; 58: 658 – 663.en_US
dc.identifier.citedreferenceKovarik JM, Mueller EA, van Bree JB, Tetzloff W, Kutz K. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 1994; 83: 444 – 446.en_US
dc.identifier.citedreferenceKahan BD, Welsh M, Urbauer DL et al. Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs. J Am Soc Nephrol 2000; 11: 1122 – 1131.en_US
dc.identifier.citedreferenceShah MB, Martin JE, Schroeder TJ, First MR. The evaluation of the safety and tolerability of two formulations of cyclosporine: NEORAL and sandimmune. A meta-analysis. Transplantation 1999; 67: 1411 – 1417.en_US
dc.identifier.citedreferencePollard SG, Lear PA, Ready AR, Moore RH, Johnson RW. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. NEORAL Renal Study Group. Transplantation 1999; 68: 1325 – 1331.en_US
dc.identifier.citedreferenceFung JJ, Starzl TE. FK506 in solid organ transplantation. Ther Drug Monit 1995; 17: 592 – 595.en_US
dc.identifier.citedreferenceJohnson C, Ahsan N, Gonwa T et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (NEORAL) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000; 69: 834 – 841.en_US
dc.identifier.citedreferenceWhite SA, Jain S, Williams ST et al. Randomized trial comparing NEORAL and tacrolimus immunousuppression for recipients of renal transplants procured from different donor groups. Transplant Proc 2000; 32: 600.en_US
dc.identifier.citedreferenceHauser IA, Neumayer HN. Tacrolimus and cyclosporine efficacy in high-risk kidney transplantation. European Multicentre Tacrolimus (FK506) Renal Study Group. Transpl Int 1998; 11 ( Suppl. 1 ): S73 – 77.en_US
dc.identifier.citedreferenceJensik SC. Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. Transplant Proc 1998; 30: 1216 – 1218.en_US
dc.identifier.citedreferenceMorris-Stiff G, Ostrowski K, Balaji V et al. Prospective randomised study comparing tacrolimus (Prograf) and cyclosporin (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases. Transpl Int 1998; 11 ( Suppl. 1 ): S334 – 336.en_US
dc.identifier.citedreferenceMayer AD, Dmitrewski J, Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997; 64: 436 – 443.en_US
dc.identifier.citedreferencePirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group [see comments]. Transplantation 1997; 63: 977 – 983.en_US
dc.identifier.citedreferenceShield CF III, McGrath MM, Goss TF. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. Transplantation 1997; 64: 1738 – 1743.en_US
dc.identifier.citedreferenceOjo AO, Meier-Kriesche HU, Hanson JA et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000; 69: 2405 – 2409.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2002.020116.x.pdf
Size:
80.18KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.